|
|
| Formerly known as: |
| M&E Biotech |
 |
| Primary Symbols & Exchanges: |
| PHARMX - Copenhagen |
| PMXAY - Pink Sheets |
| - London |
|
|
| Primary Industry: |
| Biotechnology |
|
|
SIC Industry Code:
|
|
NAICS Industry Code:
|
|
Thomson Financial Business Description:
| The Group's principal activity is to develop new drugs for the treatment of cancer and inflammatory diseases including serious chronic diseases. The Group's has developed HER-2 Protein AutoVac tm vaccine for the treatment of metastatic breast cancer. The products of the Group target chronic inflammatory diseases such as psoriasis and Crohn's disease, rheumatoid arthritis, asthma and various forms of cancer. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Pharmexa A/S
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
